Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Russell, Beth"'
Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival.
Autor:
Russell, Beth1 (AUTHOR) beth.russell@kcl.ac.uk, Sherif, Amir2 (AUTHOR), Häggström, Christel3,4 (AUTHOR), Josephs, Debra1 (AUTHOR), Kumar, Pardeep5 (AUTHOR), Malmström, Per-Uno3 (AUTHOR), Van Hemelrijck, Mieke1 (AUTHOR)
Publikováno v:
Scandinavian Journal of Urology (Taylor & Francis Ltd). Aug2019, Vol. 53 Issue 4, p206-212. 7p.
Autor:
Russell B; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Hemelrijck MV; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK., Gårdmark T; Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Sweden., Holmberg L; Department of Translational Oncology and Urology Research, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden., Kumar P; The Royal Marsden NHS Foundation Trust, London, UK., Bellavia A; Department of Environmental Health, Harvard T.H. Chan School of Public Health., Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Department of Biobank Research, Umeå University, Umeå, Sweden.
Publikováno v:
Cancer medicine [Cancer Med] 2020 Oct; Vol. 9 (20), pp. 7477-7487. Date of Electronic Publication: 2020 Aug 26.
Autor:
Beckmann K; UniSA Cancer Research Institute, University of South Australia, Adelaide, Australia. Kerri.beckmann@kcl.ac.uk.; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK. Kerri.beckmann@kcl.ac.uk., Russell B; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK., Josephs D; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK., Garmo H; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK.; Regional Cancer Centre Uppsala, Uppsala University Hospital, Uppsala, Sweden., Haggstrom C; Department of Biobank Research, Umea University, Umea, Sweden.; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Holmberg L; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK.; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Stattin P; Department of Surgical Sciences, Uppsala University Hospital, Uppsala, Sweden., Van Hemelrijck M; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK.; Unit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Adolfsson J; CLINTEC-department, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
BMC cancer [BMC Cancer] 2019 Jun 21; Vol. 19 (1), pp. 612. Date of Electronic Publication: 2019 Jun 21.